Skip to content
Unclaimed
Discovery tool, not advice. Every figure is the published rule, not a decision on your case.
Equity

AMR Action Fund

Status

Open continuously

No deadline — apply whenever you are ready.

Always open
Amount
Not published

Roughly USD 1 billion fund investing in clinical-stage antibacterial companies, with the goal of bringing two to four new antibiotics to patients by 2030.

Funder

AMR Action Fund (industry-backed)

private · supranational

Deadline: rolling — Investment opportunities reviewed on a rolling basis.

Your odds
Not published

This funder does not publish a success rate. We rank it using the rate observed across similar programmes and label it as an estimate rather than implying we know.

Effort
quick

Quick — mostly identity and bank details.

Who can apply

Targets companies with candidates in or approaching clinical development, not preclinical startups.

Apply on the funder's site

Source. https://www.amractionfund.com/ — checked 2026-08-14 · not human-checked